Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents.

Meta-analyses of randomized-controlled trials have established a heightened risk of suicidality for children and adolescents treated with selective serotonin reuptake inhibitors (SSRIs). The present study examined to what extent daily clinical practice complied with specific recommendations regardin...

Descripción completa

Detalles Bibliográficos
Publicado en:European Child & Adolescent Psychiatry Vol. 29; no. 5; pp. 707 - 719
Autores principales: Sørensen, Johanne Østerby, Rasmussen, Annette, Roesbjerg, Troels, Pagsberg, Anne Katrine
Formato: research tables/charts Journal Article
Publicado: Springer Nature May2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=143439209&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 143439209
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10188827
        EJ3
      jtl: European Child & Adolescent Psychiatry
      issn: 10188827
      maglogo: N
    pubinfo:
      dt: May2020
      vid: 29
      iid: 5
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        143439209
        143439209
        143439209
        10.1007/s00787-019-01435-0
        143439209
      ppf: 707
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Clinician compliance to recommendations regarding the risk of suicidality with selective serotonin reuptake inhibitors in the treatment of children and adolescents.
      aug:
        au:
          Sørensen, Johanne Østerby
          Rasmussen, Annette
          Roesbjerg, Troels
          Pagsberg, Anne Katrine
        affil: Department of Clinical Medicine, Faculty of Health and Medical Sciences and Child and Adolescent Mental Health Center, Mental Health Services, Capital Region of Denmark and University of Copenhagen, Kildegaardsvej 28, Opgang 3A, 1 sal, 2900, Hellerup, Denmark
      sug:
        subj:
          Guideline Adherence
          Medical Practice
          Suicidal Ideation Risk Factors
          Serotonin Uptake Inhibitors Adverse Effects
          Serotonin Uptake Inhibitors Administration and Dosage
          Depression Drug Therapy
          Pediatric Care
          Human
          Infant
          Child, Preschool
          Child
          Adolescence
          Mental Health Services
          Denmark
          Adverse Drug Event
          Odds Ratio
          Infant: 1-23 months
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Adolescent: 13-18 years
      ab: Meta-analyses of randomized-controlled trials have established a heightened risk of suicidality for children and adolescents treated with selective serotonin reuptake inhibitors (SSRIs). The present study examined to what extent daily clinical practice complied with specific recommendations regarding the risk of suicidality when treating children and adolescents with SSRIs. All in- and outpatients aged 0–17 years at the Child and Adolescent Mental Health Services, Capital Region of Denmark with a prescription for SSRI on January 1st, 2016 were identified. Data were obtained for n = 365 patients regarding the level of clinician compliance to deliver pre-consent information about adverse effects, monitor for suicidality, and provide non-pharmacological interventions. 81.7% (n = 298) of patients received pre-consent information about adverse effects. 67.7% (n = 247) were monitored for suicidality within 6 weeks after SSRI initiation. Children (0–13 years) were less likely to be monitored for suicidality compared to adolescents (14–17 years) (49.6% vs. 77.5%, p < 0.001). Patients with depression as indication for SSRI treatment were more likely to be monitored for suicidality than patients with other indications (OR = 3.4, p = 0,002) and more likely to receive information specifically about suicidality (34.7% vs. 19.7%, p = 0.002). Respectively, 89.3% (n = 326) and 93.4% (n = 341) of all SSRI-treated patients were treated with non-pharmacological interventions prior to and in parallel with SSRI treatment. For the majority of cases, treatment of children and adolescents with SSRI complied with recommendations from clinical guidelines. However, patients of younger age and/or with indications for SSRIs other than depression were less likely to be managed according to recommendations.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N